Home/Sama Therapeutics/Russell Hanson, PhD
RH

Russell Hanson, PhD

Chief Innovation Officer

Sama Therapeutics

Therapeutic Areas

Sama Therapeutics Pipeline

DrugIndicationPhase
iMAGiNE™ Platform for Clinical Trial AccelerationCognitive, Affective, Interoceptive, Substance Use DisordersDevelopment
iMAGiNE™ Platform for Clinical Decision SupportMajor Depressive Disorder, ADHD, PTSD, OCD, SchizophreniaDevelopment
iMAGiNE™ for Direct-to-Consumer Brain Health TrackingWellness, Longevity, Psychedelic Medicine IntegrationDevelopment